Login / Signup

CRISPR-Cas9 mediated one-step disabling of pancreatogenesis in pigs.

Jun WuMarcela VilarinoKeiichiro SuzukiDaiji OkamuraYanina Soledad BogliottiInsung ParkJoan RoweBret McNabbPablo Juan RossJuan Carlos Izpisua Belmonte
Published in: Scientific reports (2017)
Genome editing using programmable nucleases has revolutionized biomedical research. CRISPR-Cas9 mediated zygote genome editing enables high efficient production of knockout animals suitable for studying development and relevant human diseases. Here we report efficient disabling pancreatogenesis in pig embryos via zygotic co-delivery of Cas9 mRNA and dual sgRNAs targeting the PDX1 gene, which when combined with chimeric-competent human pluriopotent stem cells may serve as a suitable platform for the xeno-generation of human tissues and organs in pigs.
Keyphrases
  • genome editing
  • crispr cas
  • endothelial cells
  • stem cells
  • induced pluripotent stem cells
  • pluripotent stem cells
  • gene expression
  • cell therapy
  • copy number
  • transcription factor
  • high throughput
  • cancer therapy